Vtesse, LLC clinical trials
Acquired by Keenova Therapeutics plc, Feb 13, 2018 · source ↗
The registry lists 2 studies whose lead sponsor is Vtesse, LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 23, 2021.
Before and after it joined Keenova Therapeutics plc
- First submitted before Vtesse, LLC became part of Keenova Therapeutics plc
- 1
- First submitted after Vtesse, LLC became part of Keenova Therapeutics plc
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company2 studies
Something wrong with this grouping? Tell us on the Keenova Therapeutics plc page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Keenova Therapeutics plc studies →
- Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 DiseaseCompletedNCT01747135Phase 1
Sponsor listed in the registry: Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company · First submitted before Vtesse, LLC became part of Keenova Therapeutics plc
- Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) DiseaseWithdrawnNCT03687476Phase 2
Sponsor listed in the registry: Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company · First submitted after Vtesse, LLC became part of Keenova Therapeutics plc